EMR vs LUNG · P/E 34, rev $4.86B vs rev $43.3M
Emerson Electric Company (EMR) versus Pulmonx Corp (LUNG) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. LUNG currently screens at market cap $111.9M.
Not investment advice. Open the EMR and LUNG stock pages for the full models.
Not investment advice.